229 related articles for article (PubMed ID: 35203564)
1. Neutrophils-to-Lymphocyte Ratio Is Associated with Progression and Overall Survival in Amyotrophic Lateral Sclerosis.
Leone MA; Mandrioli J; Russo S; Cucovici A; Gianferrari G; Lisnic V; Muresanu DF; Giuliani F; Copetti M; The Pooled Resource Open-Access Als Clinical Trials Consortium ; Fontana A
Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203564
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of spirometric tests in Amyotrophic Lateral Sclerosis patients.
Pirola A; De Mattia E; Lizio A; Sannicolò G; Carraro E; Rao F; Sansone V; Lunetta C
Clin Neurol Neurosurg; 2019 Sep; 184():105456. PubMed ID: 31382080
[TBL] [Abstract][Full Text] [Related]
3. The amyotrophic lateral sclerosis functional rating scale predicts survival time in amyotrophic lateral sclerosis patients on invasive mechanical ventilation.
Lo Coco D; Marchese S; La Bella V; Piccoli T; Lo Coco A
Chest; 2007 Jul; 132(1):64-9. PubMed ID: 17475635
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil to Lymphocyte Ratio as a Prognostic Marker in Amyotrophic Lateral Sclerosis.
Cotet C; Alarcan H; Hérault O; Corcia P; Vourc'h P; Andres CR; Blasco H; Veyrat-Durebex C
Biomolecules; 2023 Nov; 13(12):. PubMed ID: 38136561
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil-to-lymphocyte ratio in sporadic amyotrophic lateral sclerosis.
Wei QQ; Hou YB; Zhang LY; Ou RW; Cao B; Chen YP; Shang HF
Neural Regen Res; 2022 Apr; 17(4):875-880. PubMed ID: 34472488
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of disease progression rate and related factors in amyotrophic lateral sclerosis patients at initial visit].
Zhang JH; Wang HF; Yang F; He ZQ; Feng F; Li M; Bai JM; Wang HR; Huang XS
Zhonghua Yi Xue Za Zhi; 2022 Jan; 102(3):222-227. PubMed ID: 35042292
[No Abstract] [Full Text] [Related]
7. Prediction of survival in amyotrophic lateral sclerosis: a nationwide, Danish cohort study.
Kjældgaard AL; Pilely K; Olsen KS; Jessen AH; Lauritsen AØ; Pedersen SW; Svenstrup K; Karlsborg M; Thagesen H; Blaabjerg M; Theódórsdóttir Á; Elmo EG; Møller AT; Bonefeld L; Berg M; Garred P; Møller K
BMC Neurol; 2021 Apr; 21(1):164. PubMed ID: 33865343
[TBL] [Abstract][Full Text] [Related]
8. Exploring the diagnosis delay and ALS functional impairment at diagnosis as relevant criteria for clinical trial enrolment.
Hamidou B; Marin B; Lautrette G; Nicol M; Camu W; Corcia P; Arnes-Bes MC; Tranchant C; Clavelou P; Hannequin D; Maurice G; Beauvais K; Antoine JC; Danel-Brunaud V; Viader F; Preux PM; Couratier P
Amyotroph Lateral Scler Frontotemporal Degener; 2017 Nov; 18(7-8):519-527. PubMed ID: 28762856
[TBL] [Abstract][Full Text] [Related]
9. [Revised amyotrophic lateral sclerosis functional rating scale at time of diagnosis predicts survival time in amyotrophic lateral sclerosis].
Liu XX; Fan DS; Zhang J; Zhang S; Zheng JY
Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(35):2472-5. PubMed ID: 20137433
[TBL] [Abstract][Full Text] [Related]
10. Rate of disease progression: a prognostic biomarker in ALS.
Labra J; Menon P; Byth K; Morrison S; Vucic S
J Neurol Neurosurg Psychiatry; 2016 Jun; 87(6):628-32. PubMed ID: 26152368
[TBL] [Abstract][Full Text] [Related]
11. Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model.
Westeneng HJ; Debray TPA; Visser AE; van Eijk RPA; Rooney JPK; Calvo A; Martin S; McDermott CJ; Thompson AG; Pinto S; Kobeleva X; Rosenbohm A; Stubendorff B; Sommer H; Middelkoop BM; Dekker AM; van Vugt JJFA; van Rheenen W; Vajda A; Heverin M; Kazoka M; Hollinger H; Gromicho M; Körner S; Ringer TM; Rödiger A; Gunkel A; Shaw CE; Bredenoord AL; van Es MA; Corcia P; Couratier P; Weber M; Grosskreutz J; Ludolph AC; Petri S; de Carvalho M; Van Damme P; Talbot K; Turner MR; Shaw PJ; Al-Chalabi A; Chiò A; Hardiman O; Moons KGM; Veldink JH; van den Berg LH
Lancet Neurol; 2018 May; 17(5):423-433. PubMed ID: 29598923
[TBL] [Abstract][Full Text] [Related]
12. Coffee and Tea Consumption Impact on Amyotrophic Lateral Sclerosis Progression: A Multicenter Cross-Sectional Study.
Cucovici A; Ivashynka A; Fontana A; Russo S; Mazzini L; Mandrioli J; Lisnic V; Muresanu DF; Leone MA
Front Neurol; 2021; 12():637939. PubMed ID: 34393966
[No Abstract] [Full Text] [Related]
13. Prolonged distal latency of the median motor nerve is associated with poor prognosis in amyotrophic lateral sclerosis.
Sato M; Nakamura T; Nagashima K; Fujita Y; Ikeda Y
Neurol Res; 2021 Mar; 43(3):191-198. PubMed ID: 33054692
[TBL] [Abstract][Full Text] [Related]
14. Neutrophils Are Associated with Higher Risk of Incident Amyotrophic Lateral Sclerosis in a BMI- and Age-Dependent Manner.
Cao W; Cao Z; Tian Y; Zhang L; Wang W; Tang L; Xu C; Fan D
Ann Neurol; 2023 Nov; 94(5):942-954. PubMed ID: 37554051
[TBL] [Abstract][Full Text] [Related]
15. The MITOS system predicts long-term survival in amyotrophic lateral sclerosis.
Tramacere I; Dalla Bella E; Chiò A; Mora G; Filippini G; Lauria G;
J Neurol Neurosurg Psychiatry; 2015 Nov; 86(11):1180-5. PubMed ID: 25886781
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity in ALSFRS-R decline and survival: a population-based study in Italy.
Mandrioli J; Biguzzi S; Guidi C; Sette E; Terlizzi E; Ravasio A; Casmiro M; Salvi F; Liguori R; Rizzi R; Pietrini V; Borghi A; Rinaldi R; Fini N; Chierici E; Santangelo M; Granieri E; Mussuto V; De Pasqua S; Georgoulopoulou E; Fasano A; ; Ferro S; D'Alessandro R
Neurol Sci; 2015 Dec; 36(12):2243-52. PubMed ID: 26205535
[TBL] [Abstract][Full Text] [Related]
17. Limited value of neutrophil-to-lymphocyte ratio and serum creatinine as point-of-care biomarkers of disease severity and infection mortality in patients hospitalized with COVID-19.
Tufa A; Gebremariam TH; Manyazewal T; Asrat Y; Getinet T; Hundie TG; Webb DL; Hellström PM; Genet S
PLoS One; 2022; 17(10):e0275391. PubMed ID: 36201435
[TBL] [Abstract][Full Text] [Related]
18. Eosinophils at diagnosis are elevated in amyotrophic lateral sclerosis.
Yang J; Liu T; Zhang L; Li X; Du FP; Liu Q; Dong H; Liu Y
Front Neurol; 2023; 14():1289467. PubMed ID: 38187158
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of Baseline Neutrophil-to-Lymphocyte Ratio in Metastatic Urothelial Carcinoma Patients Treated With First-line Chemotherapy: A Large Multicenter Study.
Auvray M; Elaidi R; Ozguroglu M; Guven S; Gauthier H; Culine S; Caty A; Dujardin C; Auclin E; Thibaut C; Combe P; Tartour E; Oudard S
Clin Genitourin Cancer; 2017 Jun; 15(3):e469-e476. PubMed ID: 27964892
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil-to-Lymphocyte Ratio Dynamics From Pre-diagnosis to End-Stage Amyotrophic Lateral Sclerosis (ALS): A Case Study on Association With Progression and Clinical Events.
De Jesus-Morales K; De Jesús-Rojas W; Ramos-Benitez MJ
Cureus; 2024 Apr; 16(4):e58109. PubMed ID: 38738022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
